1 |
Gorczyca D, Szponar B, Paściak M, Czajkowska A, Szmyrka M. Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study. Scand J Rheumatol 2021;:1-7. [PMID: 34169789 DOI: 10.1080/03009742.2021.1923183] [Reference Citation Analysis]
|
2 |
Oda S, Ashida K, Uchiyama M, Sakamoto S, Hasuzawa N, Nagayama A, Wang L, Nagata H, Sakamoto R, Kishimoto J, Todaka K, Ogawa Y, Nakanishi Y, Nomura M. An open-label phase Ⅰ/Ⅱ a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion. J Clin Endocrinol Metab 2021:dgab450. [PMID: 34143883 DOI: 10.1210/clinem/dgab450] [Reference Citation Analysis]
|
3 |
Liu J, Zhang D, Wang K, Li Z, He Z, Wu D, Xu Z, Zhou J. Time Course of Metabolic Alterations Associated with the Progression of Systemic Lupus Erythematosus in MRL/lpr Mice Based on GC/MS. J Proteome Res 2021;20:1243-51. [PMID: 33356297 DOI: 10.1021/acs.jproteome.0c00619] [Reference Citation Analysis]
|